References
- Abd El-Hameed M. D., Kellaway I. W. Preparation and in vitro characterisation of mucoadhesive polymeric microspheres as intranasal delivery systems. Eur. J. Pharm. Biopharm. 1997; 44: 53–60
- Critchley H., Davis S. S., Farraj N. F., Illum L. Nasal absorption of desmopressin in rats and sheep. Effect of a bioadhesive microsphere delivery system. J. Pharm. Pharmacol. 1994; 46: 651–656
- Farraj N. F., Johansen B. J., Davis S. S., Illum L. Nasal administration of insulin using bioadhesive microspheres as a delivery system. J. Cont. Rel. 1990; 13: 253–261
- Gonda I., Gipps E. Model of disposition of drugs administered into the human nasal cavity. Pharm. Res. 1990; 7: 69–75
- Harris A. S., Nilsson I. M., Wagner Z. G., Alkner U. Intranasal administration of peptides: Nasal deposition, biological response and absorption of desmopressin. J. Pharm. Sci. 1986; 75: 1085–1088
- Harris A. S., Hedner P., Vilhardt H. Nasal administration of desmopressin by spray and drops. J. Pharm. Pharmacol. 1987; 39: 932–934
- Harris A. S., Svensson E., Wagner Z. G., Lethagen S., Wilsson I. M. Effect of viscosity on particle size, deposition and clearance of nasal delivery systems containing desmopressin. J. Pharm. Sci. 1988; 77: 405–408
- Hoogstraate A. J., Verhoef J. C., Tuk B., Pijpers A., van Leengoed L.A.M.G., Verheijen J. H.M., Junginger H. E., Boddé H.E. In vivo buccal delivery of fluorescein isothiocyanate-dextran 4400 with glycodeoxycholate as an absorption enhancer in pigs. J. Pharm. Sci. 1996; 85: 457–460
- Illum L., Farraj N. F., Critchley H., Davis S. S. Nasal administration of gentamicin using a novel microsphere delivery system. Int. J. Pharm. 1988; 46: 261–265
- Illum L., Farraj N. F., Davis S. S., Johansen B. R., O'Hagan D. T. Investigation of nasal absorption of biosynthetic human growth hormone in sheep – use of bioadhesive microsphere delivery systems. Int. J. Pharm. 1990; 63: 207–211
- Mehvar R., Shepard T. L. Molecular-weight-dependent pharmacokinetics of fluorescein-labeled dextrans in rats. J. Pharm. Sci. 1992; 81: 908–912
- Morimoto K., Yamaguchi H., Iwakura Y., Morisaka K., Ohashi Y., Nakai Y. Effects of viscous hyaluronate-sodium solutions on the nasal absorption of vasopressin and an analogue. Pharm. Res. 1991; 8: 471–474
- Notari R. E., DeYoung J. L., Rewning R. H. Effect of parallel first-order drug loss from site of administration on calculated values for absorption rate constants. J. Pharm. Sci. 1972; 61: 135–138
- Oechslein C. R., Fricker G., Kissel T. Nasal delivery of octreotide: Absorption enhancement by particulate carrier systems. Int. J. Pharm. 1996; 139: 25–32
- Pennington A. K., Ratclil T. C. J. H., Wilson C. G., Hardy J. G. The influence of solution viscosity on nasal spray deposition and clearance. Int. J. Pharm. 1988; 43: 221–224
- Proctor D. F., Andersen I., Lundqvist G. Clearance of inhaled particles from the human nose. Arch. Intern. Med. 1973; 131: 132–139
- Rowland M, Tozer T. Clinical pharmacokinetics: Concepts anil Applications. Williams & Wilkins, Baltimore 1995
- Tozer T. N., Bois F. Y., Hauck W. W., Chen M.-L., Williams R. L. Absorption rate vs. exposure: Which is more useful for bioequivalencc testing?. Pharm. Res. 1996; 13: 453–456
- Yergin B.M., Saketkhoo K., Michaclson E. D., Serafini S. M., Kovitz K., Sackner M. A. A roentgenographic method for measuring nasal mucous velocity. J. Appl. Physiol. 1978; 44: 964–968